MATINAS BIOPHARMA HOLDINGS, INC. Deferred Rent Credit, Current
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Deferred Rent Credit, Current of $455.55 thousand as of 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRentCreditCurrent · last filed 2018-03-16
- 2017-12-31: Deferred Rent Credit, Current $455.55K.
- 2017-09-30: Deferred Rent Credit, Current $395.62K.
- 2017-06-30: Deferred Rent Credit, Current $11.76K.
- 2017-03-31: Deferred Rent Credit, Current $11.74K.
| Period end | Deferred Rent Credit, Current |
|---|---|
| 2017-12-31 | $455.55K 10-K · filed 2018-03-16 |
| 2017-09-30 | $395.62K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $11.76K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $11.74K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $11.48K 10-K · filed 2018-03-16 |
| 2016-09-30 | $11.23K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $10.97K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $10.22K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $9.22K 10-K · filed 2017-03-31 |
| 2015-09-30 | $8.23K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $7.24K 10-Q · filed 2015-08-13 |
| 2015-03-31 | $5.76K 10-Q · filed 2015-05-15 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |